Ann Arbor, Michigan — From blood to food to medicine, cells are all around us. However, the current methods of separating those cells from their surroundings for research, diagnostics, and cell therapy—also known as cell sorting—can be time-consuming, costly, and damaging to the cells. To address this, Ann Arbor-based startup Akadeum Life Sciences is developing […]

FREMONT, Calif. — WaferGen Bio-systems, Inc. (WGBS) today announced preliminary, unaudited revenue for the third quarter of 2015. The Company expects total revenue for the third quarter of 2015 to be in the range of $1.9 million to $2.1 million, which would represent an increase of 52-68% when compared to the $1.3 million reported for […]

SAN DIEGO — Silicon Biosystems, Inc.today announced that it was awarded a contract from the National Institutes of Health (NIH), National Cancer Institute (NCI) to provide the Center for Cancer Research (CCR) with a DEPArray system for rare, single-cell isolation. The DEPArray system combines image-based cell selection withdielectrophoresis-based cell movement for identification and sorting of […]

MANASSAS, Va.– ATCC, the premier global biological materials resource and standards organization, announces today that it has been selected by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to provide vital cell lines to academic, pharmaceutical, and biotechnology organizations committed to speed a cure for Parkinson’s disease. Parkinson’s disease is a chronic, degenerative neurological […]

FREMONT, Calif. — WaferGen Bio-systems (Nasdaq:WGBS) announced today the commercial launch and presentation of data from the ICELL8™ Single-Cell System at the American Society of Human Genetics (ASHG) annual meeting in Baltimore, MD. In the hands of world-class early access partners globally, WaferGen’s ICELL8 Single-Cell system has consistently demonstrated the power to isolate thousands of […]

BALTIMORE and SAN JOSE, Calif. — BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today launched its first dedicated product specifically for single cell genomics applications with BD FACSseq™, a high-throughput cell sorter designed for single cell genomic studies, combined with BD™ Precise Assays for […]

ALAMEDA, Calif. – BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that it has agreed to sell 1,600,000 of its common shares, no par value, at an offering price of $3.19 per share to its largest shareholder, Broadwood Partners, L.P. (“Broadwood”). […]

Darmstadt, Germany – Merck, a leading company for innovative and top-quality high-tech products in the healthcare, life science and performance materials sectors, today opened its Innovation Center in Darmstadt, thus establishing a new platform for innovations from around the world and from the Rhine-Main region. The two-floor building, which has a surface area of over […]

ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that BioTime completed a registered direct offering of 6,530,612 shares to a select group of TASE Indexes and mutual funds. The total proceeds from the share sale were NIS 80 […]

Yokogawa Electric Corporation announces the release of CellActivision, an application program for the analysis and evaluation of images of label-free cells taken using cell imaging systems or conventional microscopes. This software is also useful for controlling cell quality in regenerative medicine and iPS cell-related research. Background of Development In basic research, live cells are usually […]